$ADAP Adaptimmune Therapeutics PLC Insider Trading Week 11/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC in week 11/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | KERINS PATRICK J | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | KERINS PATRICK J | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | KERINS PATRICK J | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Mar 22 2018 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Sell | S | 1.71 | 600,000 | 1,026,000 | 0 | 600 K to 0 (-100.00 %) |